The IBD Project By Takeda at DDW

Takeda, a global leader in gastrointestinal medicine, launched The IBD Project to deepen its commitment to the community living with and treating inflammatory bowel disease. Designed to foster collaboration, education, and advocacy—especially for underrepresented groups—the initiative aims to improve patient outcomes, encourage earlier diagnosis, and reinforce Takeda’s role as a trusted partner in IBD care. At Digestive Disease Week (DDW), Takeda sought an immersive platform to introduce the program, educate healthcare professionals, and launch key digital resources including TheIBDProject.com and IBDIQ.com. Working alongside Pivot Design and Evolution Health Group, Jack Morton helped develop the strategic foundation of the campaign, translating four core messaging pillars into a dynamic exhibit experience rooted in Takeda’s values of Patient–Trust–Reputation–Business. 

The resulting 50×70 exhibit brought each pillar to life through dedicated interactive zones within an open, modular environment designed for flexibility across future events. A vibrant color palette, contemporary architecture, and innovative lighting marked a bold departure from Takeda’s traditional booth design, drawing attendees into an engaging space for education and dialogue. Knowledgeable staff guided visitors through immersive learning modules, while in-booth presentations with key opinion leaders fostered deeper discussion around IBD care. Community-driven elements—including a mosaic photo installation—encouraged connection among attendees, while thoughtful touches like inclusive hospitality options reinforced Takeda’s commitment to accessibility and patient-centered values. Together, the experience established The IBD Project as a powerful platform for collaboration, awareness, and progress in IBD care. 

THE IMPACT 

Takeda leadership praised the Jack Morton-executed exhibit at DDW, stating that it perfectly embodied their vision. This pioneering effort not only elevated Takeda’s image but also positioned them as a thought leader and an advocate for individuals living with IBD.  

The IBD Project booth at DDW was a resounding success, drawing significant engagement from attendees. The booth’s design and interactive elements attracted a steady stream of visitors, and their quantitative goals were exceeded.   

With the success of the exhibit at DDW and the modulatory of the design, Takeda Pharmaceuticals is excited to bring their IBD Project exhibit to more Congress events throughout 2024 and 2025 to continue to educate HCPs and advocate for patients living with the disease.